Marcus CS[au] - Search Results

Year	Number of Results
1962	2
1965	1
1966	2
1973	1
1975	1
1977	2
1979	1
1981	2
1982	1
1983	2
1984	1
1985	4
1986	2
1987	7
1988	9
1989	3
1990	6
1991	2
1992	2
1993	1
1994	2
1995	1
1996	2
1997	2
2000	2
2001	2
2002	3
2004	2
2007	1
2008	1
2011	1
2012	1
2013	1
2014	1
2015	1
2016	1
2017	3
2018	3
2021	0

1

How Should the FDA Review Diagnostic Radiopharmaceuticals?

Marcus CS. Marcus CS. J Nucl Med. 2018 Jun;59(6):868-870. doi: 10.2967/jnumed.117.200337. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025981 Free article.

2

Nuclear Medicine Procedures Do Not Pose Cancer Risks in Women-Unappreciated or Otherwise.

Siegel JA, Greenspan B, Silberstein EB, Sacks B, Marcus CS, Stabin MG. Siegel JA, et al. Among authors: marcus cs. J Nucl Med. 2018 Oct;59(10):1489-1490. doi: 10.2967/jnumed.118.218842. Epub 2018 Aug 30. J Nucl Med. 2018. PMID: 30166354 Free article. No abstract available.

3

Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.

Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP. Marcus CS, et al. J Cancer. 2014 Jan 1;5(1):25-30. doi: 10.7150/jca.7810. J Cancer. 2014. PMID: 24396495 Free PMC article. Review.

4

Well-Founded Recommendations for Radioactive Iodine Treatment of Differentiated Thyroid Cancer Require Balanced Study of Benefits and Harms.

Tulchinsky M, Baum RP, Bennet KG, Freeman LM, Jong I, Kairemo K, Marcus CS, Moadel RM, Suman P. Tulchinsky M, et al. Among authors: marcus cs. J Clin Oncol. 2018 Jun 20;36(18):1887-1888. doi: 10.1200/JCO.2018.78.5972. Epub 2018 May 3. J Clin Oncol. 2018. PMID: 29723091 No abstract available.

5

Destroying the Linear No-threshold Basis for Radiation Regulation: A Commentary.

Marcus CS. Marcus CS. Dose Response. 2016 Nov 6;14(4):1559325816673491. doi: 10.1177/1559325816673491. eCollection 2016 Oct-Dec. Dose Response. 2016. PMID: 27867321 Free PMC article.

6

Commentary: NRC Requests Comments on Draft Guidance.

Siegel JA, Stabin MG, Marcus CS. Siegel JA, et al. Among authors: marcus cs. J Nucl Med. 2017 Feb;58(2):18N. J Nucl Med. 2017. PMID: 28151419 Free article. No abstract available.

7

Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody.

Wagner HN Jr, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti PS. Wagner HN Jr, et al. Among authors: marcus cs. J Nucl Med. 2002 Feb;43(2):267-72. J Nucl Med. 2002. PMID: 11850494 Free article. Review.

8

The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0.

Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD. Silberstein EB, et al. Among authors: marcus cs. J Nucl Med. 2012 Oct;53(10):1633-51. doi: 10.2967/jnumed.112.105148. Epub 2012 Jul 11. J Nucl Med. 2012. PMID: 22787108 Free article. No abstract available.

9

Imaging tumors in humans with Tc-99m-VIP.

Thakur ML, Marcus CS, Saeed S, Pallela V, Minami C, Diggles L, Pham HL, Ahdoot R, Kalinowski EA, Moody T. Thakur ML, et al. Among authors: marcus cs. Ann N Y Acad Sci. 2000;921:37-44. doi: 10.1111/j.1749-6632.2000.tb06949.x. Ann N Y Acad Sci. 2000. PMID: 11193855

10

Released nuclear medicine patients, security checkpoints, and the NRC.

Siegel JA, Marcus CS. Siegel JA, et al. Among authors: marcus cs. J Nucl Med. 2008 Feb;49(2):41N-3N; discussion 43N. J Nucl Med. 2008. PMID: 18245737 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results